<DOC>
	<DOCNO>NCT03039621</DOCNO>
	<brief_summary>The purpose study obtain additional data efficacy safety Ergoferon treatment acute respiratory viral infection child age 6 month 6 year .</brief_summary>
	<brief_title>Clinical Trial Efficacy Safety Ergoferon Treatment Acute Respiratory Viral Infections Children</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<criteria>1 . Patients sex aged 6 month 6 year old . 2 . Diagnosis acute respiratory viral infection base physician examination : oral temperature least 38.0°C examination + total symptom severity score ≥5 . 3 . The first 24 hour begin manifestation acute respiratory viral infection . 4 . Patients present seasonal morbidity raise acute respiratory viral infection . 5 . Availability patient information sheet ( Informed Consent form ) sign patient 's parents/adopters confirm child 's participation clinical trial sign one parent/adopter patient . 1 . Suspected pneumonia bacterial infection ( e.g . meningitis , sepsis , otitis medium , urinary tract infection , etc . ) require antibacterial therapy start Day 1 illness onset . 2 . Suspected initial manifestation diseases symptom similar ARVI ( infectious disease , influenzalike syndrome onset Autoimmune Disorders Connective Tissue , oncohematology pathology ) . 3 . Clinical symptom severe influenza infection/ARVI require hospitalization . 4 . Medical history prior diagnosis primary secondary immunodeficient disease ; oncology disease . 5 . Exacerbation decompensation chronic disease ( diabetes mellitus , infantile cerebral palsy , mucoviscidosis/cystic fibrosis , primary ciliary dyskinesia , bronchopulmonary dysplasia , сongenital malformation respiratory system ETN , etc . ) would affect patient 's ability participate clinical trial . 6 . Malabsorption syndrome , include congenital acquire lactose intolerance/lactase deficiency disaccharidase deficiency galactosemia . 7 . Allergy/ intolerance component medication use treatment . 8 . Course intake medicine list section `` Prohibited concomitant treatment '' 2 week prior enrollment trial . 9 . Subjects whose parents/adopters , investigator 's point view , fail comply observation requirement trial intake regimen investigate medicine . 10 . Participation clinical trial within 3 month prior enrollment study . 11 . Patient 's parents/adopters relate research staff clinical investigative site directly involve trial immediate family member researcher . The immediate family member include husband/wife , parent , child brother ( sister ) , regardless whether natural adopt . 12 . The patient 's parent/adopter work OOO `` NPF `` MATERIA MEDICA HOLDING '' ( i.e. , company 's employee , temporary contract worker appoint official responsible carry research ) immediate relative .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>